C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2009
12/17/2009	US20090311177 Radiolabelling Methods
12/17/2009	DE10315030B4 Zyklische Peptide, Verfahren zu deren Herstellung und deren medizinische Verwendung Cyclic peptides, process for their preparation and to their medical use
12/17/2009	CA2727898A1 Novel antiviral peptides against influenza virus
12/17/2009	CA2727567A1 Process for preparing caspofungin and intermediates thereof
12/17/2009	CA2727485A1 Iqgap3 epitope peptides and vaccines containing the same
12/17/2009	CA2727482A1 Mybl2 epitope peptides and vaccines containing the same
12/17/2009	CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function
12/17/2009	CA2726768A1 Methods and compositions for generation of bax- and bak-deficient cell lines
12/17/2009	CA2723824A1 Biocompatible and biodegradable elastomeric polymers
12/16/2009	EP2132224A1 Cyclic receptor-associated protein (rap) peptides
12/16/2009	EP2132221A1 Template-fixed peptidomimetics
12/16/2009	EP2132219A2 Ace-inhibitory peptides from whey and methods for providing the same.
12/16/2009	EP2132218A1 Transferases, epimerases, polynucleotides encoding these and uses thereof
12/16/2009	EP2131852A1 Treatment of inflammation and/or endotoxic shock
12/16/2009	EP1636593B9 Modulating the interaction between hgf beta chain and c-met
12/16/2009	EP0996455B1 Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof
12/16/2009	CN101602795A Cyclohexalipopeptide amine antifungal compound, salts and preparation method thereof
12/16/2009	CN101602794A Method for preparing human MGF polypeptide and antibody thereof
12/16/2009	CN101602793A Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof
12/16/2009	CN100569797C Undecapeptide and application thereof
12/16/2009	CN100569796C Immune modulating peptide
12/15/2009	US7632817 Antibodies against exogeneous protein; epitopes different from those detected by antibodies; myasthenia gravis; infertility; gene therapy
12/15/2009	US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
12/15/2009	US7632805 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis
12/15/2009	US7632801 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
12/15/2009	US7632646 Tuberculosis diagnostic test
12/15/2009	US7632618 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/15/2009	US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009	US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009	CA2294996C Angiotensin derivatives
12/10/2009	WO2009149279A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
12/10/2009	WO2009149214A2 Compositions and methods for enhancing cellular transport of biomolecules
12/10/2009	WO2009149094A2 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
12/10/2009	WO2009148615A1 Cyclosporin analogs and their use in the treatment of hcv infections
12/10/2009	WO2009148343A1 Peptide analogues, particularly for the treatment of chronic pain
12/10/2009	WO2009148252A2 Stroke-targeting peptide and use thereof
12/10/2009	WO2009148230A2 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
12/10/2009	WO2009148229A2 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases
12/10/2009	WO2009147368A1 Peptides
12/10/2009	WO2009146513A1 Immunogens for controlling bovine tick
12/10/2009	WO2009122285A8 Oxytocin analogues
12/10/2009	WO2009103105A3 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
12/10/2009	US20090306343 Affinity Ligands
12/10/2009	US20090305993 Methods and composition for the treatment of gastrointestinal disorders
12/10/2009	US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
12/10/2009	US20090305960 Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
12/10/2009	US20090305955 Cyclopeptide with Anti-Cancer Activity Derived from Collagen Type IV
12/10/2009	US20090305954 Histidine-containing diastereomeric peptides and uses thereof
12/10/2009	US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/10/2009	US20090305949 Glycosylated specificity exchanger
12/10/2009	US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta )
12/10/2009	US20090305432 Polypeptide Molecular Switch
12/10/2009	US20090305340 Altered peptide ligands of gad65
12/10/2009	US20090305324 Cytotoxic t-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
12/10/2009	US20090305309 Methods and Compositions for Detecting Neoplastic Cells
12/10/2009	US20090305226 Biomolecular Recognition of Crystal Defects
12/10/2009	US20090304778 Diagnostics and Methods for Removal and Detection of Interferents
12/10/2009	US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304725 Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA
12/10/2009	US20090304713 Binding agents
12/10/2009	US20090304698 Modulation of ovulation
12/10/2009	US20090304586 Chelating Agent Conjugated Alpha-MSH Peptide Derivatives, Preparation Method Thereof and Composition for Diagnosis and Treatment of Melanoma Comprising the Same as an Active Ingredient
12/10/2009	US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	DE102008027375A1 Bacitracin-Metall-Komplexe als Bleichkatalysatoren Bacitracin-metal complexes as bleaching catalysts
12/10/2009	CA2726917A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
12/10/2009	CA2726913A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
12/10/2009	CA2726804A1 Xbp1, cd138, and cs1 peptides
12/09/2009	EP2130837A1 Novel nuclear translocation peptide
12/09/2009	EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
12/09/2009	EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009	EP2129683A2 Methods and compositions for the treatment of heart failure and other disorders
12/09/2009	EP2129682A1 Novel macromolecule transduction domains and methods for identification and uses thereof
12/09/2009	EP2129681A2 C5 antigens and uses thereof
12/09/2009	EP1963357B1 Compounds for the inhibition of apoptosis
12/09/2009	EP1444194B1 N-methyl-homocystines, use thereof and method for the production thereof
12/09/2009	CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
12/09/2009	CN101597578A Enramycin producing strain and extraction method by using macroporous resin
12/09/2009	CN101597327A O-type foot and mouth disease virus antigen epitope molecular mimic peptide and application thereof
12/09/2009	CN101597326A Kahalalide F and related compounds
12/09/2009	CN101597325A Method for purifying Leuprorelin
12/09/2009	CN101597324A Decapeptide inhibiting angiogenesis and use thereof
12/09/2009	CN101597323A Radioactive isotope labeling polypeptide for tumor imaging
12/09/2009	CN101597322A 17 analogs of Tyr-Ile-Gly-Ser-Arg as well as synthetic method and application thereof in medicine
12/09/2009	CN101597321A LHRH antagonist with long-acting low-histamine release side effect
12/09/2009	CN100567987C T cell bacterin and preparation method thereof
12/09/2009	CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same
12/08/2009	US7629438 Microbiocide for use in treatment and prevention of infection; antitumor agents
12/08/2009	US7629437 Fluorogenic materials and uses thereof
12/08/2009	US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009	US7629295 Determination of a specific immunoglobulin using multiple antigens
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/03/2009	WO2009092891A4 Modification of intrinsically disordered sequences for preparing vaccines
12/03/2009	US20090300802 Plant defense signal peptides
12/03/2009	US20090299033 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
12/03/2009	US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/03/2009	US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life
12/03/2009	US20090298755 Novel Chimeric Analgesic Peptides

1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 423